Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma

Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma

Abstract Matrix metalloproteinases (MMP) have been identified as biomarkers for several diseases, including cancer. The increase in the expression of these enzymes has been related to greater tumor aggressiveness. MMP-26 is expressed constitutively in the endometrium and some cancer cells of epithel...

Full description

Saved in:

Bibliographic Details
Main Authors:	ROMILDO LUCIANO DA SILVA, FRANCISCO LUÍS A. PAES, SANDRA MARIA S. DA SILVA, FABIANO SANTOS, EDUARDA S. DE SANTANA, JACINTO DA C. SILVA NETO
Format:	Article
Language:	English
Published:	Academia Brasileira de Ciências 2025-01-01
Series:	Anais da Academia Brasileira de Ciências
Subjects:	Immunohistochemistry metalloproteinase prostate cancer PSA
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652025000100602&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
by: Ai Sato, et al.
Published: (2025-03-01)

Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
by: Mohamed O. Andarawi, et al.
Published: (2025-02-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Metastatic gastric adenocarcinoma in prostate: A case report
by: Naru Shimizu, et al.
Published: (2025-03-01)

Urology pathways for the primary care physician
by: J John
Published: (2024-04-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Expression of MMP1, MMP3, and TIMP1 in intervertebral discs under simulated overload and microgravity conditions
by: Xuanyu Chen, et al.
Published: (2025-01-01)

A partial differential equation model of metastasized prostatic cancer
by: Avner Friedman, et al.
Published: (2013-03-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Prostate cancer perspective: Africa versus the world
by: B Marais, et al.
Published: (2024-04-01)

Comparative Study of Gleason 7 (3+4) and (4+3) Prostatic Adenocarcinomas with Prognostic Criteria and Immunohistochemical Profiles of AMACR, PSA and Ki-67
by: Clarice F. E. M. Osório, et al.
Published: (2025-01-01)

The potential contributions of matrix metalloproteinase 8,9 and 13 (MMP-8,9,13) to cerebral vasospasm and the role of doxycycline inhibitors on gene expression after experimental subarachnoid haemorrhage
by: Yasin Göktürk, et al.
Published: (2024-10-01)

A case of stromal sarcoma of the prostate with the incidental detection of prostate adenocarcinoma
by: Shang Xu, et al.
Published: (2025-03-01)

Vitamin Bs as Potent Anticancer Agents through MMP-2/9 Regulation
by: Ha Vy Thi Vo, et al.
Published: (2025-01-01)

Comparison of molecular analysis results determined by next-generation sequencing to immunohistochemical indicators and clinicopathological parameters in prostate adenocarcinomas
by: Merve Çırak Balta, et al.
Published: (2024-04-01)

Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy
by: Alireza Shoari, et al.
Published: (2024-12-01)

PSA is not suitable as a reliable marker for seminal fluid in rectal samples collected post-mortem
by: Corine Müller, et al.
Published: (2025-07-01)

Histopathological and Immunohistochemical Evaluation of African Swine Fever Pigs in Bali Province
by: Monica Septiani, et al.
Published: (2024-12-01)

Effects of colchicine adjuvant therapy on disease control, serum NALP3, sICAM-1, MMP-9 and MMP-13 in patients with coronary heart disease and acute gout attack
by: Bingxun Wang, et al.
Published: (2025-01-01)

Serum matrix metalloproteinase‐7, Syndecan‐1, and CA 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
by: Doron Yablecovitch, et al.
Published: (2024-09-01)

Clinicopathological, Histopathological, and Immunohistochemical Analysis of Mandibular Fibrosarcoma in a DSH Cat: A Case Report
by: Mahmood Ahmadi‐hamedani, et al.
Published: (2024-11-01)

Effects of local rosuvastatin/hyaluronan hydrogel on post-orthodontic relapse reduction in rabbits: Histological and immunohistochemical study
by: Saba N. Yaseen, et al.
Published: (2025-01-01)

RETRACTED ARTICLE: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
by: Zhe Rong, et al.
Published: (2013-05-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Immunohistochemical evaluation of P53 in squamous cell carcinoma of the esophagus
by: Kala K, et al.
Published: (2024-10-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
by: Juan Manuel Palacios, et al.
Published: (2025-01-01)

Mucin-producing urothelial-type adenocarcinoma of the prostate with a gene mutation characteristic of intestinal adenocarcinoma: case report and literature review
by: Ao Yu, et al.
Published: (2025-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Prostate Cancer Screening: Is it Recommended in 2024?
by: Dr. Ali Thwaini
Published: (2024-12-01)

Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
by: Lorenza Bridi Todeschini, et al.
Published: (2025-01-01)

Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray
by: Ming Lee, et al.
Published: (2022-07-01)

Influence of Polyphenol Extract from Evening Primrose (Oenothera Paradoxa) Seeds on Proliferation of Caco-2 Cells and on Expression, Synthesis and Activity of Matrix Metalloproteinases and Their Inhibitors
by: Szewczyk Karolina, et al.
Published: (2014-09-01)

The “prostate-pelvic syndrome” theory used in patients with type-III prostatitis and its correlation with prostate volume
by: Xiao-Ma Zhang, et al.
Published: (2025-01-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

Characterization of H460R, a Radioresistant Human Lung Cancer Cell Line, and Involvement of Syntrophin Beta 2 (SNTB2) in Radioresistance
by: Chang-Nim Im, et al.
Published: (2013-12-01)